Cargando…

Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation

Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. The main focus today is towards efficient screening programs, a faster diagnostic, and prompt tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostu, Raluca-Cristina, Fagarasan, Vlad, Ciuce, Catalin C., Drasovean, Radu, Gheban, Dan, Scurtu, Radu Razvan, Grama, Alina, Stefanescu, Ana Cristina, Ciuce, Constantin, Pop, Tudor Lucian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823821/
https://www.ncbi.nlm.nih.gov/pubmed/33379246
http://dx.doi.org/10.3390/medicina57010016
_version_ 1783639927469113344
author Apostu, Raluca-Cristina
Fagarasan, Vlad
Ciuce, Catalin C.
Drasovean, Radu
Gheban, Dan
Scurtu, Radu Razvan
Grama, Alina
Stefanescu, Ana Cristina
Ciuce, Constantin
Pop, Tudor Lucian
author_facet Apostu, Raluca-Cristina
Fagarasan, Vlad
Ciuce, Catalin C.
Drasovean, Radu
Gheban, Dan
Scurtu, Radu Razvan
Grama, Alina
Stefanescu, Ana Cristina
Ciuce, Constantin
Pop, Tudor Lucian
author_sort Apostu, Raluca-Cristina
collection PubMed
description Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. The main focus today is towards efficient screening programs, a faster diagnostic, and prompt treatment. However, the limited information on BA pathophysiology makes valuable any experience in disease management. This study aimed to analyze the evolution and survival of patients with BA referred for HPE (Kasai operation) in our department. Materials and Methods: A retrospective analysis was performed on fourteen patients with BA, diagnosed in the pediatric department and further referred for HPE in our surgical department between 2010 and 2016. After HPE, the need for transplantation was assessed according to patients cytomegalovirus (CMV) status, and histological and biochemical analysis. Follow-up results at 1–4 years and long term survival were assessed. Results: Mean age at surgery was 70 days. Surgery in patients younger than 60 days was correlated with survival. Jaundice’s clearance rate at three months was 36%. Total and direct bilirubin values had a significant variation between patients with liver transplants and native liver (p = 0.02). CMV was positive in eight patients, half with transplant need and half with native liver survival. Smooth muscle actin (SMA) positivity was proof of advanced fibrosis. The overall survival rate was 79%, with 75% for native liver patients and an 83% survival rate for those with liver transplantation. Transplantation was performed in six patients (43%), with a mean of 10 months between HPE and transplantation. Transplanted patients had better survival. Complications were diagnosed in 63% of patients. The mean follow-up period was six years. Conclusions: HPE, even performed in advanced cirrhosis, allows a significant survival, and ensures an essential time gain for patients requiring liver transplantation. A younger age at surgery is correlated with a better outcome, despite early CMV infection.
format Online
Article
Text
id pubmed-7823821
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78238212021-01-24 Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation Apostu, Raluca-Cristina Fagarasan, Vlad Ciuce, Catalin C. Drasovean, Radu Gheban, Dan Scurtu, Radu Razvan Grama, Alina Stefanescu, Ana Cristina Ciuce, Constantin Pop, Tudor Lucian Medicina (Kaunas) Article Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. The main focus today is towards efficient screening programs, a faster diagnostic, and prompt treatment. However, the limited information on BA pathophysiology makes valuable any experience in disease management. This study aimed to analyze the evolution and survival of patients with BA referred for HPE (Kasai operation) in our department. Materials and Methods: A retrospective analysis was performed on fourteen patients with BA, diagnosed in the pediatric department and further referred for HPE in our surgical department between 2010 and 2016. After HPE, the need for transplantation was assessed according to patients cytomegalovirus (CMV) status, and histological and biochemical analysis. Follow-up results at 1–4 years and long term survival were assessed. Results: Mean age at surgery was 70 days. Surgery in patients younger than 60 days was correlated with survival. Jaundice’s clearance rate at three months was 36%. Total and direct bilirubin values had a significant variation between patients with liver transplants and native liver (p = 0.02). CMV was positive in eight patients, half with transplant need and half with native liver survival. Smooth muscle actin (SMA) positivity was proof of advanced fibrosis. The overall survival rate was 79%, with 75% for native liver patients and an 83% survival rate for those with liver transplantation. Transplantation was performed in six patients (43%), with a mean of 10 months between HPE and transplantation. Transplanted patients had better survival. Complications were diagnosed in 63% of patients. The mean follow-up period was six years. Conclusions: HPE, even performed in advanced cirrhosis, allows a significant survival, and ensures an essential time gain for patients requiring liver transplantation. A younger age at surgery is correlated with a better outcome, despite early CMV infection. MDPI 2020-12-28 /pmc/articles/PMC7823821/ /pubmed/33379246 http://dx.doi.org/10.3390/medicina57010016 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Apostu, Raluca-Cristina
Fagarasan, Vlad
Ciuce, Catalin C.
Drasovean, Radu
Gheban, Dan
Scurtu, Radu Razvan
Grama, Alina
Stefanescu, Ana Cristina
Ciuce, Constantin
Pop, Tudor Lucian
Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
title Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
title_full Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
title_fullStr Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
title_full_unstemmed Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
title_short Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
title_sort biological and histological assessment of the hepatoportoenterostomy role in biliary atresia as a stand-alone procedure or as a bridge toward liver transplantation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823821/
https://www.ncbi.nlm.nih.gov/pubmed/33379246
http://dx.doi.org/10.3390/medicina57010016
work_keys_str_mv AT aposturalucacristina biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT fagarasanvlad biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT ciucecatalinc biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT drasoveanradu biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT ghebandan biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT scurturadurazvan biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT gramaalina biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT stefanescuanacristina biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT ciuceconstantin biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation
AT poptudorlucian biologicalandhistologicalassessmentofthehepatoportoenterostomyroleinbiliaryatresiaasastandaloneprocedureorasabridgetowardlivertransplantation